Avricore Health Inc.
AVCR.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 50.58% | 62.61% | 67.34% | 93.90% | 261.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 50.58% | 62.61% | 67.34% | 93.90% | 261.02% |
| Cost of Revenue | 29.78% | 49.07% | 45.79% | 70.85% | 300.85% |
| Gross Profit | 103.96% | 93.74% | 123.17% | 160.58% | 187.58% |
| SG&A Expenses | -11.33% | 0.11% | 32.05% | 56.76% | 95.51% |
| Depreciation & Amortization | 102.51% | 110.38% | 225.00% | 440.00% | -193.56% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.34% | 28.11% | 40.04% | 64.50% | 147.67% |
| Operating Income | 120.44% | 107.81% | 60.06% | 13.26% | -14.26% |
| Income Before Tax | 110.32% | 99.37% | 58.99% | 16.84% | -21.68% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 110.32% | 99.37% | 58.99% | 16.84% | -21.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 110.32% | 99.37% | 58.99% | 16.84% | -21.68% |
| EBIT | 120.44% | 107.81% | 60.06% | 13.26% | -14.26% |
| EBITDA | 231.08% | 236.29% | 146.78% | 65.47% | 23.11% |
| EPS Basic | 110.81% | 100.00% | 60.32% | 18.75% | -17.46% |
| Normalized Basic EPS | 108.70% | 97.62% | 58.97% | 17.95% | -9.52% |
| EPS Diluted | 110.81% | 100.00% | 60.32% | 18.75% | -17.46% |
| Normalized Diluted EPS | 108.70% | 97.62% | 58.97% | 17.95% | -9.52% |
| Average Basic Shares Outstanding | 0.68% | 0.99% | 1.42% | 1.74% | 1.69% |
| Average Diluted Shares Outstanding | 2.13% | 2.44% | 1.42% | 1.74% | 1.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |